The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Related Posts
How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy
The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other psychedelic drugs…
This Kidney Was Frozen for 10 Days. Could Surgeons Transplant It?
Scientists developed a way to freeze a large mammal’s kidney, which could ease organ shortages in the future. First, they…
Michael Stone, Psychiatrist and Scholar Who Studied Evil, Dies at 90
Dr. Michael H. Stone, a psychiatrist and scholar who sought to define evil and to differentiate its manifestations from the…